153 related articles for article (PubMed ID: 23242020)
1. [Clinical effects of bile aspiration just before contrast injection during endoscopic retrograde cholangiopancreatography].
Choi JS; Kang DH; Kim HD; Urm SH; Lee SH; Kim JH; Jee SR; Jung EU; Park SJ; Lee YJ; Seol SY
Korean J Gastroenterol; 2012 Dec; 60(6):368-72. PubMed ID: 23242020
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: experience from a Chinese center.
Yang J; Peng JY; Pang EJ; Chen W
Dig Endosc; 2013 Jul; 25(4):453-8. PubMed ID: 23363031
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
4. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
5. Post-ERCP pancreatitis: reduction by routine antibiotics.
Räty S; Sand J; Pulkkinen M; Matikainen M; Nordback I
J Gastrointest Surg; 2001; 5(4):339-45; discussion 345. PubMed ID: 11985972
[TBL] [Abstract][Full Text] [Related]
6. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
7. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial.
Hao JY; Wu DF; Wang YZ; Gao YX; Lang HP; Zhou WZ
World J Gastroenterol; 2009 Jan; 15(3):366-8. PubMed ID: 19140238
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
10. Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence.
van Westerloo DJ; Rauws EA; Hommes D; de Vos AF; van der Poll T; Powers BL; Fockens P; Dijkgraaf MG; Bruno MJ
Gastrointest Endosc; 2008 Aug; 68(2):246-54. PubMed ID: 18455169
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antibiotic use to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis.
Ishigaki T; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishii Y; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2015; 62(138):417-24. PubMed ID: 25916074
[TBL] [Abstract][Full Text] [Related]
12. Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.
Lee HS; Chung MJ; Park JY; Bang S; Park SW; Song SY; Chung JB
PLoS One; 2018; 13(2):e0190835. PubMed ID: 29401491
[TBL] [Abstract][Full Text] [Related]
13. Papillary balloon dilation is not itself a cause of post-endoscopic retrograde cholangiopancreatography pancreatitis; results of anterograde and retrograde papillary balloon dilation.
Seo YR; Moon JH; Choi HJ; Kim DC; Lee TH; Cha SW; Cho YD; Park SH; Kim SJ
J Gastroenterol Hepatol; 2013 Aug; 28(8):1416-21. PubMed ID: 23701518
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin].
Montaño Loza A; García Correa J; González Ojeda A; Fuentes Orozco C; Dávalos Cobián C; Rodríguez Lomelí X
Rev Gastroenterol Mex; 2006; 71(3):262-8. PubMed ID: 17140047
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A
World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute.
Hernández Garcés HR; Almeida Linnet A; Abreu Vázquez M; Calzadilla Bertot L; Peña K; Andrain Sierra Y; Moutary I; Segura Fernández N
Rev Gastroenterol Peru; 2014 Apr; 34(2):127-32. PubMed ID: 25028902
[TBL] [Abstract][Full Text] [Related]
17. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
18. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.
Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH
Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
[TBL] [Abstract][Full Text] [Related]
20. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
